Methotrexate and Humira are two widely recognized medications in the realm of autoimmune diseases and inflammatory conditions. As chronic illnesses afflict millions, the quest for effective treatment options has led to the discovery and development of various pharmaceuticals. Among these, Methotrexate and Humira have emerged as significant players in the management of diseases like rheumatoid arthritis, psoriasis, and Crohn’s disease. Methotrexate, initially developed as a chemotherapy agent, has gained popularity for its immunosuppressive properties, making it a cornerstone in treating several autoimmune disorders. On the other hand, Humira, a biologic drug that targets specific pathways in the immune system, represents a newer approach to managing inflammation and immune response. The…